Antimicrobial resistance - World Health Organization (WHO) Antimicrobial resistance (AMR) threatens the effective prevention and treatment of an ever-increasing range of infections caused by bacteria, parasites, viruses and fungi AMR occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of
Antimicrobial resistance - World Health Organization (WHO) Antimicrobial resistance is the broader term for resistance in different types of microorganisms and encompasses resistance to antibacterial, antiviral, antiparasitic and antifungal drugs Antimicrobial resistance occurs naturally but is facilitated by the inappropriate use of medicines, for example using antibiotics for viral infections such
Antimicrobial resistance - World Health Organization (WHO) Antimicrobial resistance refers to microorganisms no longer responding to antimicrobial medicine such as antibiotics This is a natural phenomenon that occurs over time through genetic changes in the microorganisms AMR is strongly accelerated by inappropriate use of antimicrobial medicine
Antimicrobial resistance - World Health Organization (WHO) What is antimicrobial resistance? Antimicrobial resistance is the ability of a microorganism (like bacteria, viruses, and some parasites) to stop an antimicrobial (such as antibiotics, antivirals and antimalarials) from working against it As a result, standard treatments become ineffective, infections persist and may spread to others
Antimicrobial resistance WPRO - World Health Organization (WHO) Antimicrobial resistance is a complex problem that affects all of society and is driven by many interconnected factors Single, isolated interventions have limited impact Coordinated action is required to minimize the emergence and spread of AMR
Strengthening antimicrobial resistance national action plans through . . . As part of the 79th United Nations General Assembly (UNGA), global leaders convened for the second High-Level Meeting on Antimicrobial Resistance (AMR) The leaders approved a political declaration with clear targets and actions, including a 10% reduction in human deaths related to bacterial AMR – estimated at 4 95 million annually – by 2030
WHO publishes the WHO Medically Important Antimicrobials List for Human . . . The WHO list of medically important antimicrobials for human medicine (WHO MIA List) is a risk management tool that can be used to support decision-making to minimize the impact of antimicrobial use in non-human sectors on antimicrobial resistance (AMR) in humans The WHO MIA List is created to guide international, national, and subnational
Antimicrobial Resistance - World Health Organization (WHO) Antimicrobial Resistance (AMR) occurs when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines making infections harder to treat and increasing the risk of disease spread, severe illness and death
Global research agenda for antimicrobial resistance in human health The research agenda is global in scope and focuses on antimicrobial resistance in the human health sector, especially infections caused by the WHO bacterial priority pathogens and WHO fungal priority pathogens with critical importance for antimicrobial resistance (such as Candida auris, Aspergillus fumigatus and Cryptococcus neoformans), and drug-resistant Mycobacterium tuberculosis
Bacteriophages and their use in combating antimicrobial resistance Antimicrobial resistance (AMR) poses a serious global threat to our ability to treat bacterial infections New antibiotics have often proved difficult and expensive to develop This has led to an interest in an older approach to treating microbial infections by using phages